MCAM and glioblastoma: Glioblastoma patients exhibited significant upregulation of CD29, CD44, CD81, CD146, CqQA, and histone H3 compared to healthy volunteers, with additional upregulation of C1QA, CD44, and histone H3 observed to those with stable disease [48].